While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.

A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

Eli Lilly shares have soared thanks to excitement about the company's position in the weight loss drug market.

Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

Current vice president and Democratic Party presidential nominee Kamala Harris has proposed sweeping changes designed to ...

Boehringer Ingelheim has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for ...

Momentum investing is based on the idea that stocks that have risen recently will tend to keep rising and that stocks that ...

Turkey's Huzur Devletsah is the first woman to head Eli Lilly's China affiliate since the U.S. pharma maker began operations ...

In 2020 the total market size for GLP-1 drugs was less than $4 billion . That same year, Novo Nordisk® paid $1.8 billion to purchase Emisphere's® SNAC drug delivery technology which was subsequently ...

While there's some ambiguity about the term "next generation" when it comes to weight loss therapies, one thing is clear: Unlike the current generation of weight loss drugs, the ideal weight loss ...